Sheng-li Xue, Md

This study tests whether combining two drugs, venetoclax and azacitidine, can help people with a rare type of acute leukemia that is hard to treat. About 23 newly diagnosed patients aged 15 and older will receive the treatment to see if it improves remission rates. The goal is to…